Please login to read the full text of the article.
If you have no account yet, please register now.
Posted on
Previous Article
« Amgen drug shrinks tumors in lung cancer patients with KRAS gene mutation -study Next Article
Bristol Myers’ Opdivo with Exelixis drug cuts kidney cancer death risk -study »
« Amgen drug shrinks tumors in lung cancer patients with KRAS gene mutation -study Next Article
Bristol Myers’ Opdivo with Exelixis drug cuts kidney cancer death risk -study »
Related Articles
February 18, 2021
Survival of transplant-eligible newly diagnosed MM in FORTE trial
February 18, 2021
Deep and durable responses with ide-cel in RRMM
© 2021 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy